Flourish Research - San Antonio

Investigational Weight Loss Medication Self-Scheduler

Basic criteria 

  • Are you ≥ 18 years old? 
  • Is your BMI between 30 and 50? OR 
  • Is your BMI between 27-29 with at least one treated or untreated risk factor? [calculate here]
    • High blood pressure, high cholesterol, obstructive sleep apnea or cardiovascular disease? 

Answers Must be NO 

  • If female, are you currently pregnant or nursing? 
  • Do you have any current or past diagnosis of type 1, type 2, or gestational diabetes or currently use any glucose lowering medications? (untreated prediabetes A1C <6.4% are ok) 
  • Do you have uncontrolled high blood pressure (≥160/100)? 
  • Have you had a body weight change of 11 lbs. or more in the past 3 months? 
  • Do you have any prior or planned weight loss surgery, or placement of a weight loss device? The following are allowed if completed at least 1 year ago:  
  • Liposuction, laparoscopic banding, gastric sleeve, intragastric balloon. 
  • Do you have any severe psychiatric disorders like schizophrenia, bipolar affective disorder? 
  • Do you have a history of or currently abuse/misuse drug or alcohol? 
  • Have you used Adderall or amphetamine containing products in the past 12months OR any GLP-1/medications that could impact weight in the past 6 months? 
  • Do you have any significant gastric emptying abnormality like gastroparesis or are you taking any drugs to treat GI motility disorders like GERD or IBS? 
  • Do you have any current HIV, CKD stage 3-5, Hep B or Hep C? 
  • Have you had any symptoms for gallbladder disease in the past 2 years, or gallbladder surgery within the past 3months? 
  • Have you had any heart attack, stroke, unstable angina, coronary or carotid revascularization procedure within the past 3 months? 
  • Are you currently receiving any glucocorticoids (prednisolone, hydrocortisone, etc.) or have any autoimmune abnormality that will require use of glucocorticoid during the study? 
  • Do you have any frequent intermittent or chronic tachyarrhythmia syndromes like AFIB? 
  • Do you have any current or past diagnosis of chronic pancreatitis, or any acute pancreatitis within the past 6 months? 
  • Do you have any history of cancer within the past 5 years, any personal or family history of medullary carcinoma or multiple endocrine neoplasia type 2 (MEN2), or uncontrolled thyroid disease? 
  • Is your obesity due to any endocrine or genetic disorders? 
  • Do you have a history of organ transplant, any history of or current significant medical or psychiatric disorder that would make you unfit for study participation? 
  • Have you donated more than 1 unit of blood (≥ 500 mL) of blood in the past 2 months or had any blood transfusion/severe blood loss in the past 3 months? 
  • Have you used any investigation drug/device or participated in a clinical trial in the past 2 months? 

Answers Must be YES 

  • If you are taking any lipid treatments, have you been stable for at least 30 days? 
  • If female and of childbearing potential, do you agree to use a condom and one of the following highly effective contraception from screening visit and until 90days after last dose of study drug? 
  • Hormonal contraception; oral, implantable and injectable at least 4 weeks prior to screening. 
  • IUD, [bilateral tubal occlusion/ligation at least 6 months prior to screening] 
  • Vasectomized partner 
  • Females in same sex relationship 
  • Complete abstinence throughout the study and for 3 months after last study dose 
  • If female and not of childbearing potential, are you; 
  • Premenopausal with a documented hysterectomy, bilateral salpingectomy or bilateral oophorectomy? OR 
  • Postmenopausal for at least 12months? 
  • If male (vasectomized) with a partner of childbearing potential or currently pregnant or nursing, do you agree to use additional barrier contraception like condoms and (or) have your partner on effective birth control throughout the study and until 90days after last dose? 

 

 

Compensation up to $2,400 may be available for time and travel

Insurance is not required.

PLEASE NOTE: Please confirm your eligibility before your appointment by calling 210-714-0067

If you do not see an available appointment, please call: 210-714-0067

Transportation may be available. Call 210-714-0067

Schedule Appointment
Flourish Research News

Stay current with the latest clinical trial news and learn how Flourish Research is supporting the advancement of life-changing therapeutics.